24/7 Market News Snapshot 06 October, 2025 – OneMedNet Corp Class A Common Stock (NASDAQ:ONMD)
DENVER, Colo., 06 October, 2025 (www.247marketnews.com) – (NASDAQ:ONMD) are discussed in this article.
OneMedNet Corp (ONMD) is experiencing a remarkable surge in its stock price, reaching $1.426 in pre-market trading—a significant increase of 38.45% from the previous close of $1.030. This rise is accompanied by robust trading activity, with approximately 8.95 million shares exchanged, indicating strong investor confidence and heightened market interest. Analysts are closely observing these developments for potential breakout patterns, suggesting that ONMD may be on the verge of further advances.
In a strategic move to enhance its market position, OneMedNet has entered into a transformative partnership with Palantir Technologies aimed at redefining the healthcare AI and Real-World Data (RWD) analytics landscape. This collaboration will utilize Palantir’s cutting-edge Artificial Intelligence Platform to augment OneMedNet’s iRWD™ provider network. By enabling access to anonymized, regulatory-grade clinical data with unprecedented speed, this partnership is set to facilitate significant advancements for life sciences companies and medical research organizations navigating the complexities of clinical data acquisition.
With the healthcare industry expected to tap into an $868 billion market opportunity driven by AI by 2030, OneMedNet seeks to address the critical challenge of quality data access. By leveraging its extensive provider network—which includes over 5 billion administrative claims and 131 million clinical exams spanning more than 1,750 healthcare sites—OneMedNet is positioned to offer scalable, recurring revenue opportunities within a secure, regulatory-compliant framework.
The multi-year agreement with Palantir will streamline data discovery, drastically reducing the time required to meet customer inquiries from days to mere minutes. This partnership not only enhances OneMedNet’s operational efficiency but also fosters market expansion and the development of innovative healthcare solutions. The collaboration underscores a shared commitment to improving patient outcomes, marking a significant milestone for both companies in their pursuit of advancing healthcare through innovative technology solutions.